Senores Pharmaceuticals Ltd

NSE: SENORES · BSE: 544319 · Pharmaceuticals & Biotechnology · 40 announcements

Share price: ₹1,391.10
Market cap: ₹6,407 Cr
Revenue (annual): ₹632.6 Cr
Net profit (annual): ₹115.4 Cr
P/E (TTM): 50.7×Sector 47.4×
Promoter holding: 45.82%+0.00% QoQ
FII holding: 6.62%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

27 Jul 2026 19:20 IST NSE

Senores Pharmaceuticals Earnings Call Transcript: Key Takeaways

Senores Pharmaceuticals delivered strong Q1 FY27 growth, doubling approved ANDAs to 58. Management is pivoting strategy toward profitability in domestic branded generics while scaling US operations via new specialized subsidiaries.

Call: Guides 35% growth

Open call summary → Read the filing ↗

27 Jul 2026 15:52 IST NSE

Earnings Call

Senores Pharmaceuticals Investor Presentation: Key Takeaways

Senores Pharmaceuticals delivered robust Q1FY27 performance with revenue growing 36% and EBITDA 87% YoY, driven by strong growth in regulated markets and margin expansion of ~800 bps.

Open call summary → Read the filing ↗